Covered recipient · General Payments record
JODI GILMER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$373.87
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.53 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $94.64 | 6 |
| Exact Sciences Corporation | $45.20 | 2 |
| ABIOMED | $44.04 | 2 |
| Lilly USA, LLC | $43.15 | 2 |
| PFIZER INC. | $21.60 | 1 |
| Acerta Pharma LLC | $17.01 | 1 |
| ABBVIE INC. | $15.71 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.18 | 1 |
| Athena Bioscience, LLC | $8.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.71 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815790 | CMS |
| ABIOMED | $21.57 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142305621 | CMS |
| ABIOMED | $22.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142305623 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.01 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105763738 | CMS |
| Athena Bioscience, LLC | $8.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096070634 | CMS |
| Exact Sciences Corporation | $20.64 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114598289 | CMS |
| Exact Sciences Corporation | $24.56 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114598293 | CMS |
| Lilly USA, LLC | $21.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135711348 | CMS |
| Lilly USA, LLC | $22.15 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135711350 | CMS |
| Novo Nordisk Inc | $17.35 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100342386 | CMS |
| Novo Nordisk Inc | $15.35 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100563439 | CMS |
| Novo Nordisk Inc | $13.55 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100387829 | CMS |
| Novo Nordisk Inc | $16.13 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100454810 | CMS |
| Novo Nordisk Inc | $14.98 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100519259 | CMS |
| Novo Nordisk Inc | $17.28 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100397796 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.18 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119031904 | CMS |
| PFIZER INC. | $21.60 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131867318 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.